Thomas A. Fey

3,5-Bis(trifluoromethyl)pyrazoles:  A Novel Class of NFAT Transcription Factor Regulator

Stevan W. Djurić, Nwe Y. BaMaung, Anwer Basha et al. · Journal of Medicinal Chemistry · 2000 · 120 citations

Life Sciences, Immunology, Pharmacology +16

Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis.

Karl W. Mollison, Włodek Mandecki, Erik R. P. Zuiderweg et al. · Proceedings of the National Academy of Sciences · 1989 · 119 citations · Full text

Life Sciences, Biochemistry, Immunology +17

Zotarolimus, a Novel Sirolimus Analogue With Potent Anti-proliferative Activity on Coronary Smooth Muscle Cells and Reduced Potential for Systemic Immunosuppression

Yung‐Wu Chen, Morey L. Smith, Michael P. Sheets et al. · Journal of Cardiovascular Pharmacology · 2007 · 81 citations

Medicine, Pharmacokinetics, Pharmacology +15

Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-<i>N</i>-(adamant-2-yl) Acetamide 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors

Jeffrey J. Rohde, Marina Pliushchev, Bryan K. Sorensen et al. · Journal of Medicinal Chemistry · 2006 · 77 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Hepatic Glucocorticoid Receptor Antagonism Is Sufficient to Reduce Elevated Hepatic Glucose Output and Improve Glucose Control in Animal Models of Type 2 Diabetes

Peer B. Jacobson, Thomas W von Geldern, Lars Öhman et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 77 citations · Full text

Medicine, Endocrinology, Pharmacology +16